Swiss National Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.6M | Buy |
|
|||||
|
2025
Q1 | $48.1M | Buy |
|
|||||
|
2024
Q4 | $68.9M | Sell |
|
|||||
|
2024
Q3 | $60.2M | Buy |
|
|||||
|
2024
Q2 | $54.1M | Sell |
|
|||||
|
2024
Q1 | $47.2M | Sell |
|
|||||
|
2023
Q4 | $36.6M | Sell |
|
|||||
|
2023
Q3 | $37M | Sell |
|
|||||
|
2023
Q2 | $30M | Sell |
|
|||||
|
2023
Q1 | $39M | Sell |
|
|||||
|
2022
Q4 | $41.1M | Sell |
|
|||||
|
2022
Q3 | $38.1M | Buy |
|
|||||
|
2022
Q2 | $35.3M | Buy |
|
|||||
|
2022
Q1 | $43.7M | Buy |
|
|||||
|
2021
Q4 | $34.5M | Sell |
|
|||||
|
2021
Q3 | $44.3M | Sell |
|
|||||
|
2021
Q2 | $46.2M | Buy |
|
|||||
|
2021
Q1 | $49.9M | Buy |
|
|||||
|
2020
Q4 | $40.7M | Sell |
|
|||||
|
2020
Q3 | $39M | Sell |
|
|||||
|
2020
Q2 | $54.3M | Buy |
|
|||||
|
2020
Q1 | $38.7M | Buy |
|
|||||
|
2019
Q4 | $37.5M | Sell |
|
|||||
|
2019
Q3 | $27.7M | Buy |
|
|||||
|
2019
Q2 | $36.8M | Buy |
|
|||||
|
2019
Q1 | $56M | Buy |
|
|||||
|
2018
Q4 | $54.5M | Buy |
|
|||||
|
2018
Q3 | $75.5M | Sell |
|
|||||
|
2018
Q2 | $89.7M | Buy |
|
|||||
|
2018
Q1 | $57.9M | Sell |
|
|||||
|
2017
Q4 | $66.8M | Buy |
|
|||||
|
2017
Q3 | $61.5M | Buy |
|
|||||
|
2017
Q2 | $115M | Buy |
|
|||||
|
2017
Q1 | $110M | Sell |
|
|||||
|
2016
Q4 | $132M | Buy |
|